Aceto to distribute Verdezyne biochemical in U.S.
October 6, 2016
By Maria Church
Oct. 6, 2016 - Verdezyne Inc., a synthetic biology company producing biobased chemicals, and Aceto Corporation, the leader in the marketing, sales and distribution of specialty chemicals in the U.S., announced an agreement for sales and distribution of 's BIOLON DDDA (biobased dodecanedioic acid). BIOLON DDDA will be produced by Verdezyne and will be distributed in the United States of America by Aceto.
Verdezyne’s BIOLON DDDA is produced more sustainably than traditional petroleum-derived intermediate chemicals and will be used to make a variety of end-user products including automotive parts, coatings, cosmetics, and fragrances.
“The market is interested in high-quality renewable chemicals such as our BIOLON, which can be used in the production of high-performance nylon 6,12, molding resins, lubricants, adhesives and powder coatings,” said E. William Radany, Ph.D., president and CEO of Verdezyne. “We are excited to bring BIOLON to the U.S. market with Aceto, a highly respected distributor of specialty chemicals. We are certain that through this partnership we will be able to continue to provide excellent customer service and high-quality products to the market.”
“Aceto is very excited to add BIOLON to our product offering of polymer building blocks,” commented Keith Wilkinson, vice president, specialty chemicals Aceto. “We are also excited to add a biobased product to our portfolio that can be offered at competitive prices.”
Verdezyne is a synthetic biology company offering biobased chemicals developed using proprietary metabolic pathway engineering tools. The company’s first product, BIOLON DDDA, earned the USDA Certified Biobased Product label, and is available worldwide. Current investors in Verdezyne include BP Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby. For more information, visit www.verdezyne.com or connect with the company on Twitter, LinkedIn or Facebook.
Aceto Corporation, incorporated in 1947 and with offices and operations in 10 countries, is engaged in the development, marketing, sale and distribution of Human Health products (finished dosage form generics and nutraceuticals), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products).
Print this page